Evidence map›Paper›PMID 17193686›Full record

ArticleContrast media & molecular imaging

Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.

Liora Shiftan, Michal Neeman

Abstract readEvaluation Study
In one paragraph

Article in Contrast media & molecular imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. MRI Contrast Agents in Glycobiology.Molecules (Basel, Switzerland) · 2022
    Review
  3. Article
  4. Review
  5. Detecting enzyme activities with exogenous MRI contrast agents.Chemistry (Weinheim an der Bergstrasse, Germany) · 2014
    Review
  6. Review
  7. Review
  8. Molecular imaging and targeted therapies.Biochemical pharmacology · 2010
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Liora ShiftanDepartment of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel.
Michal Neeman
Weizmann Institute of Science · IL

Funding

MRI STUDIES OF ANGIOGENESIS IN OVARIAN CANCERR01CA075334 · NCI · WEIZMANN INSTITUTE OF SCIENCE · PI NEEMAN, MICHAL · 1998 to 2015
$1.6M
NCI NIH HHS R01 CA075334NCI NIH HHS R01 CA75334
6 · The paper itself

Abstract

One of the attractions of molecular imaging using 'smart' bioactive contrast agents is the ability to provide non-invasive data on the spatial and temporal changes in the distribution and expression patterns of specific enzymes. The tools developed for that aim could potentially also be developed for functional imaging of enzyme activity itself, through quantitative analysis of the rapid dynamics of enzymatic conversion of these contrast agents. High molecular weight hyaluronan, the natural substrate of hyaluronidase, is a major antiangiogenic constituent of the extracellular matrix. Degradation by hyaluronidase yields low molecular weight fragments, which are proangiogenic. A novel contrast material, HA-GdDTPA-beads, was designed to provide a substrate analog of hyaluronidase in which relaxivity changes are induced by enzymatic degradation. We show here a first-order kinetic analysis of the time-dependent increase in R(2) as a result of hyaluronidase activity. The changes in R(2) and the measured relaxivity of intact HA-GdDTPA-beads (r(2B)) and HA-GdDTPA fragments (r(2D)) were utilized for derivation of the temporal drop in concentration of GdDTPA in HA-GdDTPA-beads as the consequence of the release of HA-GdDTPA fragments. The rate of dissociation of HA-GdDTPA from the beads showed typical bell-shaped temperature dependence between 7 and 36 degrees C with peak activity at 25 degrees C. The tools developed here for quantitative dynamic analysis of hyaluronidase activity by MRI would allow the use of activation of HA-GdDTPA-beads for the determination of the role of hyaluronidase in altering the angiogenic microenvironment of tumor micro metastases.

Indexed as

AnimalsCarcinomaContrast MediaEnzyme ActivationFemaleGadolinium DTPAHumansHyaluronoglucosaminidaseKineticsMagnetic Resonance ImagingMiceMice, NudeOvarian NeoplasmsTemperatureTransplantation, HeterologousTumor Cells, CulturedContrast MediaGadolinium DTPAHyaluronoglucosaminidase

Identifiers

PMID17193686
PMCPMC4035508
OpenAlexW2069827154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.